| Net Cash Provided by (Used in) Operating Activities |
-74K |
USD |
+18.7% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
-66.5M |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
66.5M |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
200M |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Common Stock, Shares, Issued |
2.27M |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-74K |
USD |
+18.7% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
273K |
USD |
+10719% |
Q2 2024 |
Q2 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Authorized |
2M |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Unrecognized Tax Benefits |
0 |
USD |
|
Q2 2025 |
Q2 2025 |
| Additional Paid in Capital |
150K |
USD |
|
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |